Firms

Zinc Investment Management LLP

Zinc Investment Management LLP

zinc.vc

UK pre-seed venture investor and venture builder operating as Zinc, with investment management conducted by Zinc Investment Management LLP. It backs science-led companies addressing health and environmental challenges, including neuroscience, AI, biotechnology, medical devices, advanced materials and clean energy. Zinc invests from the earliest stages of company creation and combines first-cheque funding with scientific assessment, commercial development and founder support. Its Science-for-Impact strategy helps researchers and entrepreneurs turn scientific discoveries into scalable businesses. The manager’s published leadership includes co-founders Paul Kirby and Ella Goldner as managing partners, and co-founder Saul Klein as a board member.

Founded
—
Type
Venture capital

Funds1

  • Zinc Science-for-Impact Fund—

    Zinc’s second institutional fund, publicly disclosed on September 2, 2026. It targets a £70 million fund size and a portfolio of 80 new UK deep-tech companies working in health and the environment, including engineering, biology and AI. The British Business Bank agreed to commit up to £46 million through its Enterprise Capital Funds programme. This is an LP commitment and the £70 million figure is a target; a verified aggregate amount raised or final close was not disclosed in the announcement. The legal vehicle name is not established by this source. Zinc II’s earlier 2022 commitment is a separate fund outside this research window.

Team

Saul Klein
Saul Klein

Zinc Investment Management LLP, Co-founder and Board Member

$1M$100K – $3MLondon

Operations and support

Claire HankeyFinance Director
David HerbadaVenture Partner
Eleanor FordChief People Officer
Ella GoldnerCo-founder and Managing Partner
Emilie SyedInvestment Principal
Kate HyslopHead of Marketing
Lily McfarlanePartner, Product
Mark BaileyVenture Partner
Martin SellersHead Venture Partner, Environment
Natalie PankovaPartner, Health & Life Sciences
Paul KirbyCo-founder and Managing Partner

Co-investing

Novaterra
Oxford Technology Management
P53 Invest

Investments